Harlan Levine, MD
President, Strategy and Business Ventures
City of Hope
Cancer care is a complex—and often controversial—topic, with multiple stakeholders that view “value” through many different lenses. Hear what value in cancer care means to patients and their caregivers and how this meaning is usually different for payers and employers. Then consider how we define value in oncology reflects on us as a society. Strategize how these different perspectives fit together to yield a value equation that takes into account outcomes, patient experience, cost, and time…and yet it is not enough. Each stakeholder brings their own perspective to the relative value of these variables, resulting in solutions that address some issues while creating new ones. Hear about the role you can play in defining oncology value going forward, and in so doing, help drive to a better—and more equitable—cancer care delivery system.
About Dr. Levine
Learn more: @drharlanlevine
Debra Patt, MD, PhD, MBA, FASCO
Executive Vice President, Public Policy and Strategic Initiatives
As healthcare systems navigated how to best keep patients with cancer safe during COVID-19, it resulted in dramatic drops in access to care, including preventative screenings, cancer management visits, and surgeries. Now that pandemic restrictions are lifting, the impact on disease progression, cancer morbidity, and death rates have yet to be realized.
Learn strategies to increase awareness and ramp up screening efforts in your own community through programs like “Time to Screen,” a nationwide campaign that offers assistance and educational resources to connect patients with appropriate screenings and services.
About Dr. Patt
Debra Patt, MD, PhD, MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer research, serves on the US Oncology Research Breast Cancer Committee, and chairs the breast cancer subsection of the pathways task force for The US Oncology Network. Dr. Patt has expertise in healthcare policy and has testified before Congress to protect access to care for Medicare beneficiaries. She is a leader in clinical cancer informatics, and is involved in system innovations to enhance care delivery across a national network of oncology practices.
Dr. Patt is President of the Texas Society of Clinical Oncology, Secretary for the Community Oncology Alliance, and serves on the Council on Legislation or the Texas Medical Association. She is a nationally recognized leader in cancer research, has published many articles, and leads the service line for breast health services for the Dell Medical School.
Learn more: @dapattmd